, Tracking Stock Market Picks
Enter Symbol:
Ista Pharmaceuticals, Inc. (ISTA) [hlAlert]

up 235.42 %

Ista Pharmaceuticals, Inc. (ISTA) rated Buy with price target $3.50 by Roth Capital

Posted on: Wednesday,  Apr 2, 2008  8:25 AM ET by Roth Capital

Roth Capital rated Buy Ista Pharmaceuticals, Inc. (NASDAQ: ISTA) on 04/02/2008. Previously Roth Capital rated Buy Ista Pharmaceuticals, Inc. (NASDAQ: ISTA) on
03/07/2008., when the stock price was $2.71. Since then, Ista Pharmaceuticals, Inc. has gained 235.42% as of 06/05/2012's recent price of $9.09.
If you would have followed the previous Roth Capital's recommendation on ISTA, you would have gained 235.42% of your investment in 1551 days.

Ista Pharmaceuticals discovers and develops new remedies for diseases and conditions of the eye. The company's product development efforts involve mixtures of a natural enzyme called hyaluronidase. The company targets serious conditions of the eye such as vitreous hemorrhage, diabetic retinopathy, corneal opacification and keratoconus. Each of these conditions affects a significant number of patients and has limited treatment options.

ROTH researches emerging growth equities in the media, technology, telecommunications, healthcare, consumer, energy and industrial sectors. The research is focused on companies with market capitalization of between $100 million - $1 billion. Our coverage universe includes approximately 180 small cap growth companies around the globe including several companies from China. With an average market cap of approximately $500 million, our objective is to identify rapidly growing companies with significant long term growth prospects.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/2/2008 8:25 AM Buy
1.44 3.50
as of 12/24/2008
1 Week up  1.03 %
1 Month up  8.33 %
3 Months up  95.00 %
1 YTD up  170.83 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/7/2008 8:25 AM Buy
2.71 7.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy